World Nuclear Medicine Market in PET/SPECT Imaging and Therapy with Current Trends and Forecasts

  May 3, 2017    |      Life Sciences    |       587


New York City, NY, May 3, 2017/24 Market Reports: The market research studies the radiopharmaceutical market with respect to the types of radioisotopes, route of administration, indication, and applications. The mention of applications for radiopharmaceuticals implies both diagnosis and treatment.

FDG and technetium (Tc 99m) radiopharmaceuticals are the radioisotopes mainly used for the diagnosis of diseases such as cancer and cardiac diseases. The market is mainly driven by the increasing incidence of cancer and cardiac diseases, early and accurate diagnosis, rising PET and SPECT installations, and awareness. The leading players are GE Healthcare, Covidien, IBA, Siemens Healthcare (Germany), and POLATOM (Poland).

Henri Becquerel, a French physicist and a noble laureate discovered “radiation” in the year 1896. It was named as radioactivity by Marie Curie; this led to the foundation of radioactivity in the world. Georg de Hevesy, J.A. Christiansen, and Sven Lomholt were the first to perform a radiotracer study in animals in the year 1924. After the discovery of radiotracer it was used to carry out different experiments such as the one which demonstrates that phosphorous is the main component of bone. Phosphorous-32 was the first artificial radionuclide used for treating leukemia in the year 1936.

Emilio Segre and Glenn Seaborg discovered technetium-99m and this affected the entire industry. This was followed by discovery of other isotopes such as iodine-131, which were used for treatment and diagnosis. Iodine-131 was the first U.S. Food and Drug Administration approved radiopharmaceutical. In the 1950’s, scintillating camera was invented, which formed the basis for rectilinear scanner, that was later used in PET and SPECT. In 1960, technetium generator hit the market, increasing the availability of technetium for various applications.

Radiopharmaceuticals are used for the diagnosis and treatment of various diseases such as cancer, cardiac, bone scan, and others. This report analyzes the radiopharmaceuticals market by types of isotopes, route of administration, and applications. Radiopharmaceuticals used in SPECT are technetium, thallium, gallium, yttrium, erbium, and others. Of all these radiopharmaceuticals, technetium accounts for the largest share. In PET, FDG radiopharmaceutical is majorly used. Radiopharmaceuticals are used for the diagnosis of various indications such as cancer, cardiac diseases, neuroimaging, bone scan, and others.

 

Browse Full Report at :- https://www.24marketreports.com/life-sciences/nuclear-medicine-equipment-market-by-product-spect-hybrid-spect-standalone-spect-hybrid-pet-26-planar-scintigraphy-application-cardiology-oncology-26-neurology-26-by-end-user-hospitals-imaging-centers---global-forecasts-to-2020